Cited by 2,222Cancer Cells and MetastasisCellular Mechanics and InteractionsLymphatic System and Diseases

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Heldin, Carl-Henrik, Rubin, Kristofer, Pietras, Kristian, Östman, Arne·2004·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

Many solid tumours show an increased interstitial fluid pressure (IFP), which forms a barrier to transcapillary transport. This barrier is an obstacle in tumour treatment, as it results in inefficient uptake of therapeutic agents. There are a number of factors that contribute to increased IFP in the tumour, such as vessel abnormalities, fibrosis and contraction of the interstitial matrix. Lowering the tumour IFP with specific signal-transduction antagonists might be a useful approach to improving anticancer drug efficacy.

Integrity signals

Registry

Crossref · 10.1038/nrc1456

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,100
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,985
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,357
Angiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L. H., Croll, S. D., Glazer, N. L., Holash, J. A., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,314
Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,074
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Bałuk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 987
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D. J., Wain, J. R., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 982

Flagged first, then by citations

Show all 78 references

Research works printed but not linked: 1

Kristensen, C. A. et al. Reduction of interstitial fluid pressure after TNF-α treatment of three human melanoma xenografts. Br. J. Cancer 74, 533–536 (1996). · DOI

Sorted by citations

Items 501–600 of 1,003

High Interstitial Fluid Pressure Is Associated with Tumor-Line Specific Vascular Abnormalities in Human Melanoma Xenografts
Simonsen, T. G., Gaustad, J., Leinaas, M. N., & Rofstad, E. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040006 · Cited by 78
From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers
MacEwan, S. R., & Chilkoti, A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201610819 · Cited by 77
Decrease in Tumor Interstitial Pressure for Enhanced Drug Intratumoral Delivery and Synergistic Tumor Therapy
Fu, Y., Ye, F., Zhang, X., He, Y., Li, X., Tang, Y., Wang, J., & Gao, D. (2022) · ACS Nano · doi:10.1021/acsnano.2c06356 · Cited by 79
Integrative models of vascular remodeling during tumor growth
Rieger, H., & Welter, M. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1295 · Cited by 79
Tumor interstitial fluid — A treasure trove of cancer biomarkers
Gromov, P., Gromova, I., Olsen, C. J., Wielenga, V. T., Talman, M.-L., Serizawa, R., & Moreira, J. M. A. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.01.013 · Cited by 77
Organ-on-a-Chip: Design and Simulation of Various Microfluidic Channel Geometries for the Influence of Fluid Dynamic Parameters
Pisapia, F., Balachandran, W., & Rasekh, M. (2022) · Applied Sciences · doi:10.3390/app12083829 · Cited by 76
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
Yun, W. S., Kim, J., Lim, D.-K., Kim, D.-H., Jeon, S. I., & Kim, K. (2023) · Nanomaterials · doi:10.3390/nano13152225 · Cited by 76
Chemical synthesis, molecular modelling, and evaluation of anticancer activity of some pyrazol-3-one Schiff base derivatives
Bensaber, S. M., Allafe, H. A., Ermeli, N. B., Mohamed, S. B., Zetrini, A., Alsabri, S. G., Erhuma, M., Hermann, A., Jaeda, M. I., & Gbaj, A. M. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1064-3 · Cited by 76
Microfluidic technologies for anticancer drug studies
Valente, K. P., Khetani, S., Kolahchi, A. R., Sanati‐Nezhad, A., Suleman, A., & Akbari, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.010 · Cited by 76
Simultaneous evaluation of anti-EGFR-induced tumour and adverse skin effects in a microfluidic human 3D co-culture model
Hübner, J., Raschke, M., Rütschle, I., Gräßle, S., Hasenberg, T., Schirrmann, K., Lorenz, A., Schnurre, S., Lauster, R., Maschmeyer, I., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33462-3 · Cited by 80
Interstitial flows promote amoeboid over mesenchymal motility of breast cancer cells revealed by a three dimensional microfluidic model
Huang, Y. L., Tung, C.-K., Zheng, A., Kim, B. J., & Wu, M. (2015) · Integrative Biology · doi:10.1039/c5ib00115c · Cited by 75
Targeting of the tumor microenvironment by curcumin
Fu, X., He, Y., Li, M., Huang, Z., & Najafi, M. (2021) · BioFactors · doi:10.1002/biof.1776 · Cited by 79
Synergistic Antitumor Activity of Taxol and Immunotoxin SS1P in Tumor-Bearing Mice
Zhang, Y., Xiang, L., Hassan, R., Paik, C. H., Carrasquillo, J. A., Jang, B., Le, N., Ho, M., & Pastan, I. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0346 · Cited by 75
Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma
Deng, C., Zhang, Q., Fu, Y. S., Sun, X., Gong, T., & Zhang, Z. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b13738 · Cited by 76
Nanoparticles Penetrate into the Multicellular Spheroid-on-Chip: Effect of Surface Charge, Protein Corona, and Exterior Flow
Huang, K., Boerhan, R., Liu, C., & Jiang, G. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00726 · Cited by 74
Ultrasound Microbubble Treatment Enhances Clathrin-Mediated Endocytosis and Fluid-Phase Uptake through Distinct Mechanisms
Fekri, F., Santos, R. C. D., Karshafian, R., & Antonescu, C. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156754 · Cited by 68
Collagenase-Encapsulated pH-Responsive Nanoscale Coordination Polymers for Tumor Microenvironment Modulation and Enhanced Photodynamic Nanomedicine
Liu, J., Tian, L., Zhang, R., Dong, Z., Wang, H., & Liu, Z. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17684 · Cited by 74
In vitro models of tumor vessels and matrix: Engineering approaches to investigate transport limitations and drug delivery in cancer
Seo, B. R., DelNero, P. F., & Fischbach, C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.011 · Cited by 75
Imaging Tumour Angiogenesis
Jeswani, T. (2005) · Cancer Imaging · doi:10.1102/1470-7330.2005.0106 · Cited by 74
A simple method for measuring interstitial fluid pressure in cancer tissues
Özerdem, U., & Hargens, A. R. (2005) · Microvascular Research · doi:10.1016/j.mvr.2005.07.003 · Cited by 74
Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility
Stritzker, J., Weibel, S., Seubert, C., Götz, A., Tresch, A., van Rooijen, N., Oelschlaeger, T. A., Hill, P. J., Gentschev, I., & Szalay, A. A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.02.004 · Cited by 74
Immunobiology of the sentinel lymph node and its potential role for antitumour immunity
Kim, R., Emi, M., Tanabe, K., & Arihiro, K. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70975-5 · Cited by 74
α5β1-Integrin promotes tension-dependent mammary epithelial cell invasion by engaging the fibronectin synergy site
Miroshnikova, Y. A., Rozenberg, G. I., Cassereau, L., Pickup, M. W., Mouw, J. K., Ou, G., Templeman, K. L., Hannachi, E.-I., Gooch, K. J., Sieminski, A. L., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-02-0126 · Cited by 74
Micro RNA‐143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer
Naito, Y., Sakamoto, N., Oue, N., Yashiro, M., Sentani, K., Yanagihara, K., Hirakawa, K., & Yasui, W. (2014) · Cancer Science · doi:10.1111/cas.12329 · Cited by 73
Side view thrombosis microfluidic device with controllable wall shear rate and transthrombus pressure gradient
Muthard, R. W., & Diamond, S. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41332b · Cited by 73
Emerging Antineoplastic Biogenic Gold Nanomaterials for Breast Cancer Therapeutics: A Systematic Review
Saravanan, M., Vahidi, H., Medina-Cruz, D., Vernet-Crua, A., Mostafavi, E., Stelmach, R., Webster, T. J., Mahjoub, M. A., Rashedi, M., & Barabadi, H. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s240293 · Cited by 77
The role of imaging in targeted delivery of nanomedicine for cancer therapy
Li, P., Wang, D., Hu, J., & Yang, X. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114447 · Cited by 75
Tailored nanoplatforms with detachable ‘meteorolite’ for photothermal-enhanced programmed tumor therapy
Zhao, Q., Zhang, Y., Yu, T., Lu, J., Sun, G., Luo, X., & Wang, S. (2022) · Carbon · doi:10.1016/j.carbon.2022.07.073 · Cited by 73
Dual-Stage Irradiation of Size-Switchable Albumin Nanocluster for Cascaded Tumor Enhanced Penetration and Photothermal Therapy
He, P., Lei, Q., Yang, B., Shang, T., Shi, J., Ouyang, Q., Wang, W., Xue, L., Kong, F., Li, Z., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c02965 · Cited by 73
Recent advances in liposome-based targeted cancer therapy
Fidan, Y. G., Muçaj, S., Timur, S. S., & Gürsoy, R. N. (2023) · Journal of Liposome Research · doi:10.1080/08982104.2023.2268710 · Cited by 76
Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy
Feng, Y., Tang, Q., Wang, B., Yang, Q., Zhang, Y., Lei, L., & Li, S. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03005-2 · Cited by 80
Nano-enabled delivery of diverse payloads across complex biological barriers
Ross, K. A., Brenza, T. M., Binnebose, A. M., Phanse, Y., Kanthasamy, A. G., Gendelman, H. E., Salem, A. K., Bartholomay, L. C., Bellaire, B. H., & Narasimhan, B. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.039 · Cited by 72
Apparent diffusion coefficient correlation with oesophageal tumour stroma and angiogenesis
Aoyagi, T., Shuto, K., Okazumi, S., Hayano, K., Satoh, A., Saitoh, H., Shimada, H., Nabeya, Y., Kazama, T., & Matsubara, H. (2012) · European Radiology · doi:10.1007/s00330-011-2359-0 · Cited by 73
Tumor Thickness at the Tumor-normal Interface: A Novel Pathologic Indicator of Chemotherapy Response in Hepatic Colorectal Metastases
Maru, D. M., Kopetz, S., Boonsirikamchai, P., Agarwal, A., Chun, Y. S., Wang, H., Abdalla, E. K., Kaur, H., Charnsangavej, C., Vauthey, J., et al. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181eb2f7b · Cited by 73
Light-Activated Core–Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer
Meng, Q., Meng, J., Ran, W., Wang, J., Zhai, Y., Zhang, P., & Li, Y. (2018) · ACS Nano · doi:10.1021/acsnano.7b09210 · Cited by 73
The intra-tumoral relationship between microcirculation, interstitial fluid pressure and liposome accumulation
Stapleton, S., Milosevic, M., Tannock, I. F., Allen, C. J., & Jaffray, D. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.008 · Cited by 73
Hyaluronan in adipogenesis, adipose tissue physiology and systemic metabolism
Zhu, Y., Kruglikov, I. L., Akgul, Y., & Scherer, P. E. (2019) · Matrix Biology · doi:10.1016/j.matbio.2018.02.012 · Cited by 68
Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine
Zhang, C., Xie, H.-Y., Zhang, Z., Wen, B., Cao, H., Bai, Y., Che, Q., Guo, J., & Su, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.829796 · Cited by 72
Microfluidics meets 3D cancer cell migration
Mehta, P., Rahman, Z., ten Dijke, P., & Boukany, P. E. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.03.006 · Cited by 78
Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances
Jia, Y., Chen, S., Wang, C., Sun, T., & Yang, L. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.990145 · Cited by 73
Collagen Complexity Spatially Defines Microregions of Total Tissue Pressure in Pancreatic Cancer
Nieskoski, M. D., Marra, K. A., Gunn, J. R., Hoopes, P. J., Doyley, M. M., Hasan, T. G., Trembly, B. S., & Pogue, B. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-10671-w · Cited by 75
Nanoparticles in Medicine: Current Status in Cancer Treatment
Pavelić, K., Pavelić, S. K., Bulog, A., Agaj, A., Rojnić, B., Čolić, M., & Trivanović, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612827 · Cited by 73
Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer
Antonarakis, E. S., & Armstrong, A. J. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.23 · Cited by 74
Tumor‐Targeting Multifunctional Nanoparticles for siRNA Delivery: Recent Advances in Cancer Therapy
Ku, S. H., Kim, K., Choi, K., Kim, S. H., & Kwon, I. C. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300607 · Cited by 72
Regulation of invadopodia by mechanical signaling
Parekh, A., & Weaver, A. M. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.10.038 · Cited by 73
Synergizing Upconversion Nanophotosensitizers with Hyperbaric Oxygen to Remodel the Extracellular Matrix for Enhanced Photodynamic Cancer Therapy
Li, J., Huang, J., Ao, Y., Li, S., Yu, M., Yu, Z., Zhu, L., Lan, X., Zhu, Y., Zhang, Y., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b07090 · Cited by 74
Emerging nanomedicines for anti-stromal therapy against desmoplastic tumors
Han, X., Xu, Y., Geranpayehvaghei, M., Anderson, G. J., Li, Y., & Nie, G. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119745 · Cited by 74
Noninvasive Magnetic Resonance Imaging of Transport and Interstitial Fluid Pressure in Ectopic Human Lung Tumors
Hassid, Y., Furman‐Haran, E., Margalit, R., Eilam, R., & Degani, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3289 · Cited by 71
Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes
Moholkar, D. N., Kandimalla, R., Gupta, R. C., & Aqil, F. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216220 · Cited by 74
A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis
Sugahara, K. N., Scodeller, P., Braun, G. B., de Mendoza, T. H., Yamazaki, C. M., Kluger, M. D., Kitayama, J., Alvarez, E. A., Howell, S. B., Teesalu, T., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.009 · Cited by 71
Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors
Wang, S., Shin, I. S., Hancock, H. A., Jang, B., Kim, H.-S., Lee, S. M., Zderic, V., Frenkel, V., Pastan, I. H., Paik, C. H., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.025 · Cited by 72
Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system
Wang, Y., Yang, T., Wang, X., Dai, W., Wang, J., Zhang, X., Li, Z., & Zhang, Q. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.027 · Cited by 70
The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies
Fokas, E., McKenna, W. G., & Muschel, R. J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9394-4 · Cited by 70
Intratumor Heterogeneity and Its Impact on Drug Distribution and Sensitivity
Nerini, I. F., Morosi, L., Zucchetti, M., Ballerini, A., Giavazzi, R., & D’Incalci, M. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.105 · Cited by 71
Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment
Kang, T., Zhu, Q., Jiang, D., Feng, X., Feng, J., Jiang, T., Yao, J., Jing, Y., Song, Q., Jiang, X., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.037 · Cited by 70
Multimodality Imaging of Silica and Silicon Materials In Vivo
Karaman, D. Ş., Sarparanta, M. P., Rosenholm, J. M., & Airaksinen, A. J. (2018) · Advanced Materials · doi:10.1002/adma.201703651 · Cited by 69
Strategies and challenges to improve the performance of tumor-associated active targeting
Zhang, Y., Cao, J., & Yuan, Z. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00289e · Cited by 70
Targeting Tumors Using Peptides
Scodeller, P., & Asciutto, E. K. (2020) · Molecules · doi:10.3390/molecules25040808 · Cited by 65
Barrier permeation and improved nanomedicine delivery in tumor microenvironments
Liu, J., Zhang, J., Gao, Y., Jiang, Y., Guan, Z., Xie, Y., Hu, J., & Chen, J. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216166 · Cited by 75
Hyaluronan degrading silica nanoparticles for skin cancer therapy
Scodeller, P., Catalano, P. N., Salguero, N., Durán, H., Wolosiuk, A., & Soler‐Illia, G. J. A. A. (2013) · Nanoscale · doi:10.1039/c3nr02787b · Cited by 69
Ultrasound-enhanced drug delivery in prostate cancer xenografts by nanoparticles stabilizing microbubbles
Eggen, S., Fagerland, S.-M. T., Mørch, Y. A., Hansen, R., Søvik, K. S., Berg, S., Furu, H., Bøhn, A. D., Lilledahl, M. B., Angelsen, A., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.020 · Cited by 69
Nanodrugs based on peptide-modulated self-assembly: Design, delivery and tumor therapy
Li, S., Xing, R., Chang, R., Zou, Q., & Yan, X. (2017) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2017.12.004 · Cited by 69
A Review on the Scope of Photothermal Therapy–Based Nanomedicines in Preclinical Models of Colorectal Cancer
Khot, M. I., Andrew, H., Svavarsdottir, H. S., Armstrong, G., Quyn, A. J., & Jayne, D. G. (2019) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2019.02.001 · Cited by 68
Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trials
Huang, A., Pressnall, M. M., Lu, R., Huayamares, S. G., Griffin, J. D., Groer, C. E., DeKosky, B. J., Forrest, M. L., & Berkland, C. J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.029 · Cited by 69
Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
Liu, J., Yuan, Q., Guo, H., Guan, H., Hong, Z., & Shang, D. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116310 · Cited by 68
B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity
Wu, M.-R., Zhang, T., Gacerez, A. T., Coupet, T. A., DeMars, L. R., & Sentman, C. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402517 · Cited by 68
Lymphangiogenesis in post-natal tissue remodeling: Lymphatic endothelial cell connection with its environment
Paupert, J., Sounni, N. E., & Noël, A. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.002 · Cited by 68
The metabolic cooperation between cells in solid cancer tumors
Icard, P., Kafara, P., Steyaert, J., Schwartz, L. H., & Lincet, H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.002 · Cited by 74
Disk-shaped magnetic particles for cancer therapy
Goiriena‐Goikoetxea, M., Muñoz, D., Orue, I., Fdez-Gubieda, M. L., Jeffrey Bokor, A., Muela, A., & García-Arribas, A. (2020) · Applied Physics Reviews · doi:10.1063/1.5123716 · Cited by 67
Multimodal Decorations of Mesoporous Silica Nanoparticles for Improved Cancer Therapy
Barui, S., & Cauda, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060527 · Cited by 73
Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features
Ballestín, A., Armocida, D., Ribecco, V., & Seano, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1347877 · Cited by 70
New perspectives in ovarian cancer treatment
Schmid, B. C., & Oehler, M. K. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.11.009 · Cited by 67
Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for Paclitaxel
Danhier, F., Magotteaux, N., Učakar, B., Lecouturier, N., Brewster, M. E., & Véronique Préat, A. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.015 · Cited by 67
Biological rationale for the design of polymeric anti-cancer nanomedicines
Zhou, Y., & Kopec̆ek, J. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.723213 · Cited by 67
Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors
Danhier, F., Danhier, P., Saedeleer, C. J. D., Fruytier, A., Schleich, N., Rieux, A. D., Sonveaux, P., Gallez, B., & Véronique Préat, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.01.009 · Cited by 68
Promising Approaches to Circumvent the Blood–Brain Barrier: Progress, Pitfalls and Clinical Prospects in Brain Cancer
Papademetriou, I. T., & Porter, T. M. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.48 · Cited by 70
A Microfluidic Tumor‐on‐a‐Chip for Assessing Multifunctional Liposomes' Tumor Targeting and Anticancer Efficacy
Ran, R., Wang, H., Hou, F., Liu, Y., Hui, Y., Petrovsky, N., Zhang, F., & Zhao, C. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900015 · Cited by 67
Emerging theranostic silver and gold nanobiomaterials for breast cancer: Present status and future prospects
Saravanan, M., Barabadi, H., Vahidi, H., Webster, T. J., Medina-Cruz, D., Mostafavi, E., Vernet-Crua, A., Cholula-Diaz, J. L., & Periakaruppan, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821013-0.00004-0 · Cited by 67
Recent advancements of antiangiogenic combination therapies in ovarian cancer
An, D., Banerjee, S. N., & Lee, J. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102224 · Cited by 70
Specific imaging of VEGF‐A expression with radiolabeled anti‐VEGF monoclonal antibody
Stollman, T. H., Scheer, M. G. W., Leenders, W. P. J., Verrijp, K. C. N., Soede, A. C., Oyen, W. J. G., Ruers, T. J. M., & Boerman, O. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23404 · Cited by 66
A Highly Efficient Tumor‐Targeting Nanoprobe with a Novel Cell Membrane Permeability Mechanism
Lei, Z., Ding, L., Yao, C., Mo, F., Li, C., Huang, Y., Yin, X., Li, M., Liu, J., Zhang, Y., et al. (2019) · Advanced Materials · doi:10.1002/adma.201807456 · Cited by 65
Metal-polyphenol-network coated CaCO3 as pH-responsive nanocarriers to enable effective intratumoral penetration and reversal of multidrug resistance for augmented cancer treatments
Dong, Z., Hao, Y., Li, Q., Yang, Z., Zhu, Y., Liu, Z., & Feng, L. (2020) · Nano Research · doi:10.1007/s12274-020-2972-9 · Cited by 65
Biological Therapies in the Treatment of Cancer—Update and New Directions
Papiez, M. A., & Krzyściak, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111694 · Cited by 72
Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy
Mooney, R., Weng, Y., Garcia, E. P., Bhojane, S., Smith‐Powell, L., Kim, S. U., Annala, A. J., Aboody, K. S., & Berlin, J. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.015 · Cited by 66
Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models
Koonce, N. A., Quick, C. M., Hardee, M. E., Jamshidi‐Parsian, A., Dent, J. A., Paciotti, G. F., Nedosekin, D. A., Dings, R. P. M., & Griffin, R. J. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.07.2275 · Cited by 65
Non-specific binding and steric hindrance thresholds for penetration of particulate drug carriers within tumor tissue
Dancy, J. G., Wadajkar, A. S., Schneider, C. S., Mauban, J. R. H., Goloubeva, O. G., Woodworth, G. F., Winkles, J. A., & Kim, A. J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.034 · Cited by 64
Nanoparticle-based drug delivery systems: What can they really do in vivo?
Wang, Y.-F., Liu, L., Xue, X., & Liang, X. (2017) · F1000Research · doi:10.12688/f1000research.9690.1 · Cited by 67
Nanosac, a Noncationic and Soft Polyphenol Nanocapsule, Enables Systemic Delivery of siRNA to Solid Tumors
Kim, H., Yuk, S. A., Dieterly, A. M., Kwon, S., Park, J., Meng, F., Gadalla, H. H., Cadena, M. J., Lyle, L. T., & Yeo, Y. (2021) · ACS Nano · doi:10.1021/acsnano.0c08694 · Cited by 63
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
Morosi, L., Meroni, M., Ubezio, P., Nerini, I. F., Minoli, L., Porcu, L., Panini, N., Colombo, M., Blouw, B., Kang, D. W., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02070-x · Cited by 65
CAR T Cell Locomotion in Solid Tumor Microenvironment
Nguyen, D., Ogando‐Rivas, E., Liu, R., Wang, T., Rubin, J. A., Jin, L., Tao, H., Sawyer, W. W., Méndez‐Gómez, H. R., Cascio, M., et al. (2022) · Cells · doi:10.3390/cells11121974 · Cited by 65
Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo
Reshetov, V., Lassalle, H., François, A., Dumas, D., Hupont, S., Gräfe, S., Filipe, V., Jiskoot, W., Guillemin, F. H., Zorin, V. P., et al. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51002 · Cited by 64
Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts
Vlahovic, G., Ponce, A. M., Rabbani, Z. N., Salahuddin, F. K., Zgonjanin, L., Spasojević, I., Vujaskovic, Z., & Dewhirst, M. W. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603941 · Cited by 64
Treatment of 9L Gliosarcoma in Rats by Ferrociphenol-Loaded Lipid Nanocapsules Based on a Passive Targeting Strategy via the EPR Effect
Huynh, N. T., Morille, M., Bejaud, J., Legras, P., Vessières, A., Jaouen, G., Benoît, J., & Passirani, C. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0501-y · Cited by 64
Interstitial Fluid Pressure as a Prognostic Factor in Cervical Cancer Following Radiation Therapy
Yeo, S., Kim, J.-S., Cho, M.-J., Kim, K.-H., & Js, K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0560 · Cited by 64
Theranostic applications of antibodies in oncology
Fleuren, E. D. G., Versleijen‐Jonkers, Y. M. H., Heskamp, S., van Herpen, C. M. L., Oyen, W. J. G., van der Graaf, W. T. A., & Boerman, O. C. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.010 · Cited by 66
Therapeutic implications of tumor interstitial fluid pressure in subcutaneous RG-2 tumors
Navalitloha, Y. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-007 · Cited by 64
Hyaluronidase-triggered anticancer drug and siRNA delivery from cascaded targeting nanoparticles for drug-resistant breast cancer therapy
Ding, J., Liang, T., Zhou, Y., He, Z., Min, Q., Jiang, L., & Zhu, J. (2016) · Nano Research · doi:10.1007/s12274-016-1328-y · Cited by 64
Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy
Kadel, D., Zhang, Y., Sun, H., Zhao, Y., Dong, Q., & Qin, L. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09461-z · Cited by 62
An update on dual targeting strategy for cancer treatment
Taghipour, Y. D., Zarebkohan, A., Salehi, R., Rahimi, F., Torchilin, V. P., Hamblin, M. R., & Seifalian, A. M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.044 · Cited by 69
Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody
Shen, J., Vil, M. D., Prewett, M. C., Damoci, C., Zhang, H., Li, H., Jimenez, X., Deevi, D. S., Iacolina, M. D., Kayas, A., et al. (2009) · Neoplasia · doi:10.1593/neo.09278 · Cited by 64

Authors: Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A.
Affiliations: Ludwig Cancer Research (SE)
Uppsala University (SE)
University of California, San Francisco (US)
Karolinska Institutet (SE)
Corresponding author: Heldin, Carl-Henrik
ORCID: Heldin, Carl-Henrik
Rubin, Kristofer
Pietras, Kristian
Östman, Arne
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-10
Volume: 4
Issue: 10
Pages: 806-813
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1456
OpenAlex: W2028156849
Cited by: 2,222
References: 78
Citations by year: 2026: 121 · 2025: 110 · 2024: 118 · 2023: 119 · 2022: 163 · 2021: 158 · 2020: 158 · 2019: 123 · 2018: 123 · 2017: 135 · 2016: 133 · 2015: 110 · 2014: 117 · 2013: 124 · 2012: 87
FWCI: 3.19
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Funders: Cancerfonden
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Keywords: interstitial fluid pressure, solid tumors, tumor microenvironment, tumor fibrosis, anticancer drug delivery, tumor hypoxia
MeSH terms: Alprostadil, Animals, Antineoplastic Agents, Biological Transport, Bradykinin, Humans, Hyaluronoglucosaminidase, Hydrostatic Pressure, Neoplasms, Niacinamide, Platelet-Derived Growth Factor, Tumor Necrosis Factor-alpha, Signal Transduction, Transforming Growth Factor beta, Vascular Endothelial Growth Factor A, Extracellular Fluid, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks